Skip to section navigation
Skip to page content

Research Projects on Health and Care

Smoke-free environments and the advertising of tobacco and related products
Although EU member states are generally compliant with national rules on smoke-free environments and tobacco-related advertising, some areas require closer scrutiny, including protecting children from the harms of smoking.
04 Jan 2022
Assessing EHR for infectious disease surveillance, prevention and control
Electronic health records (EHR) data could greatly help infectious disease surveillance, but their use varies across Europe. Researchers mapped EHR use to assess the feasibility of using EHR data for infectious disease surveillance.
10 Dec 2021
Assessing POCT for infectious disease surveillance, prevention and control
Researchers examined the availability of point-of-care testing (POCT) devices to diagnose 56 communicable diseases and related health issues under EU surveillance — not including COVID-19 — and mapped trends in the use of POCT in Europe.
02 Dec 2021
Making outcome-based payment a reality in the NHS: Phase 2
To prepare for the implementation of a pilot scheme to pay for cancer drugs based on achieved outcomes, researchers addressed issues identified in the first phase of research, such as the quality and completeness of real-world data on key patient outcomes.
23 Nov 2021
Understanding how rail construction affects mental health and wellbeing
Researchers are exploring how the UK's High-Speed Rail 2 development might affect people who live near the railway line. What they learn will contribute to the design and assessment of later phases of the HS2 scheme.
18 Nov 2021
Reviewing the work and health research landscape
Researchers mapped the funding landscape for work and health research in the UK for the first time. They examined how much has been spent in the area since 2015, what types of research topic are funded and what the priorities for future work and health research should be.
29 Oct 2021
The impact of antimicrobial resistance on modern medicine
Most research on antimicrobial resistance (AMR) focuses on its effects on communicable diseases. But AMR can result in a wide variety of negative outcomes for patients with non-communicable health conditions and/or who are exposed to certain healthcare services.
30 Sep 2021
Communicating research evidence to health and care governance boards
A study of health and care board members in England found that boards engage with research evidence in various capacities when making decisions, but many expressed an appetite for improving the ways and extent to which research evidence is used at the board level.
28 Sep 2021
Supporting Your DNA, Your Say
RAND Europe is providing support to the Your DNA, Your Say project in terms of design and implementation of the analysis of survey data and reporting results in scientific papers.
08 Jul 2021
Insights into the health and wellbeing of Canadian workers
RAND Europe researchers analysed data from 70 Canadian organisations and 7,251 employees that participated in Wellness Report surveys on employee lifestyle, mental health and other areas of concern. The reports assess the associated impact these areas have on health and productivity.
04 Jun 2021
Supporting prioritisation and evaluation of mental health funding related to urgent and emergency care
Researchers produced a guide to help local NHS systems and partnerships determine spending and planning priorities and then evaluate selected projects for mental health urgent and emergency care.
30 Apr 2021
Liaison and Diversion services save money through reduced sentencing
An evaluation of NHS England's Liaison and Diversion programme found that it successfully engages people with a broad range of vulnerabilities and halves their likelihood of receiving a custodial sentence.
12 Apr 2021
Can workplace financial interventions support the mental health of young adults?
Participation in workplace financial wellbeing interventions is associated with better mental health, particularly amongst certain subgroups of workers, according to survey data from healthiest workplace competitions.
08 Mar 2021
Examining COVID-19 and intimate partner violence
Researchers identified 27 practices that—to varying degrees—have ensured the continuity, accessibility and sustainability of support to women victims during the COVID-19 pandemic.
08 Mar 2021
Evaluation design for multiple long-term health conditions programme
Complex evaluations at multiple levels are gathering evidence for Guy’s and St Thomas’ Charity on societal determinants of health such as housing, debt, racism and labour markets. The findings will inform policy to help those most at risk of developing long-term conditions.
29 Jan 2021
Examining the use of Paediatric Early Warning Systems in the UK
A diverse range of paediatric early warning (PEW) systems are commonly used across the UK, particularly in acute settings. A review of their use uncovered a growing interest amongst some healthcare decisionmakers in the potential of using a standardised system.
25 Jan 2021
Reviewing the use and effectiveness of arts-based approaches for public engagement with research
To raise awareness about a research topic, increase research impact, or help inform the research process and direction, taking an arts-based approach may help to engage the public.
11 Jan 2021
How to help patients to access and use online services in primary health care
Researchers are exploring the potential benefits and challenges associated with different models of digital facilitation for primary care, and will design a framework for future evaluations of the effectiveness of such interventions.
05 Jan 2021
Independent evaluation of the Flow Coaching Academy programme
To help improve patient flow through the healthcare system, researchers evaluated a novel programme that applies team coaching skills and improvement science at the care pathway level.
25 Nov 2020
COVID-19 and the cost of vaccine nationalism
Without a vaccine, the worldwide economic impact of COVID-19 could be $3.4 trillion a year. But even when a vaccine is available, an unequal allocation of COVID-19 vaccines could cost the global economy up to $1.2 trillion a year in GDP.
28 Oct 2020

Page 4 of 8
Previous
1
2
3
4
5
6
7
8
Next